You are currently viewing a new version of our website. To view the old version click .

Bioactive Molecules from Marine Microorganisms

Special Issue Information

Dear Colleagues,

Marine microorganisms, including bacteria, fungi, and microalgae, represent an untapped source of bioactive metabolites. Considering their great metabolic diversity and the fact that only a small fraction of all marine microorganisms has been identified, many products are still waiting to be discovered. These compounds not only help the microorganisms to survive in different conditions and habitats, but they can also be used as templates for the development of new pharmaceuticals, and as components of cosmeceuticals, nutraceuticals, and other health-related products. Among the effects most frequently attributed to natural products of marine microorganisms, cytotoxic, anticoagulant, antibacterial, antiviral, neurotoxic, and immune-modulating activities have been observed.

This Special Issue aims to collect papers on the most recent findings in the field of “Bioactive Molecules from Marine Microorganisms”. We are interested in new data on the source organisms and biosynthetic pathways of the bioactive metabolites and their chemical structures, biological activity, mode of action, isolation, and alternative methods of production as well as biotechnological potential, especially as medical agents. Comprehensive review papers that present up-to-date knowledge on bioactive products from marine microorganisms are also welcome.

Prof. Dr. Hanna Mazur-Marzec
Dr. Anna Toruńska-Sitarz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine microorganisms
  • natural products
  • biosynthesis
  • genome mining
  • biological activity
  • structure elucidation
  • bioprospecting
  • bacteria
  • fungi
  • actinomycetes
  • cyanobacteria
  • microalgae

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Mar. Drugs - ISSN 1660-3397